SOURCE: Trident Brands, Inc.

Trident Brands, Inc.

May 27, 2016 10:34 ET

Dr. Neilank Jha Presentation to Professional Hockey Trainers Highlights Brain Armor® Tour

BROOKFIELD, WI--(Marketwired - May 27, 2016) - Trident Brands, Inc. (OTCQB: TDNT), an emerging growth company focused on identifying and building growth brands in dynamic consumer segments, today announced that a key advisor to its Brain Armor® subsidiary, Dr. Neilank Jha, will address the Professional Hockey Athletic Trainers Society at their annual meeting on June 24, 2016. A leading neurosurgeon, Dr. Jha is a well-known advocate for encouraging sports participation while managing head injury risks.

Brain Armor® has a strong following with professional and collegiate level sports. Its customers include professional baseball, football, hockey and basketball teams as well as Division I NCAA programs across the country. Its 2016 education tour includes appearances, many by invitation, at key events focused on the elite athlete community:

  • Professional Baseball Athletic Trainers Society (December 4, 2015 / Nashville)
  • Collegiate Strength & Conditioning Coaches Association Conference (May 4-6, 2016 / Fort Worth, TX)
  • Collegiate and Professional Sports Dietitians Association Conference and Symposium (May 11-14, 2016 / Kansas City, MO)
  • National Basketball Athletic Trainers Association Sports Medicine and Product Trade Show (May 14, 2016 / Chicago, IL)
  • Professional Hockey Athletic Trainers Society Annual Meeting (June 24-29, 2016 / Nashville, TN)
  • National Strength and Conditioning Association Conference (July 6-9, 2016 / New Orleans, LA)

Explains Don MacPhee, President & CEO, Trident Brands, "There is growing interest in the elite athlete community on how to strengthen the brain, to prepare for competition. Brain Armor® is well positioned because it is pure plant based DHA -- the omega-3 that nourishes the brain. And we are thrilled that Dr. Jha, our special advisor, has been invited to share his extensive knowledge with pro hockey trainers."

About Brain Armor®

Brain Armor® is the highest single capsule dose of plant based DHA on the market. It is NSF certified for sport, and has garnered a following with professional and collegiate athletes. Brain Armor® features life'sDHA®, a pure plant based DHA sourced from a sustainable process in an FDA inspected facility. DHA is especially concentrated in the gray matter of the brain, the retina of the eyes and heart tissue. Trident Brands holds an exclusive worldwide license from Royal DSM to market Brain Armor®.

About Dr. Neilank Jha

Dr. Jha is a board certified Neurosurgeon FRCS(C) and a fellowship trained Spine Surgeon. He is one of the foremost concussion experts in North America, with published articles, papers and book chapters, as well as presenting various abstracts at scientific meetings in Canada and the United States. Dr. Jha is the Founder of the KONKUSSION program. His vision is to revolutionize and redefine the management of concussions.

About Trident Brands, Inc.

Trident Brands, Inc. is an emerging growth company focused on identifying and building growth brands in dynamic consumer segments. The company's management team has expertise in developing and commercializing consumer products in global companies and specialty markets. Trident is currently targeting growth opportunities in brand and consolidated licenses, consumer goods such as functional foods, supplements, and beverages, life science technologies that have applications in consumer products, and intellectual property and/or licenses in recognized brand platforms.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and the Company's future performance, operations, and products. Such statements involve known and unknown risks, uncertainties and other factors that could cause the Company's actual results to differ materially from the results expressed or implied by such statements. Such risks and uncertainties include, without limitation, market acceptance of the Company's forthcoming line of nutritional products; the Company's compliance with applicable Food and Drug Administration regulations; the Company's reliance on third-party contractors to mix and produce its products; the Company's ability to develop an effective marketing strategy; the Company's ability to control advertising and marketing costs; the Company's ability to develop and increase awareness of its forthcoming brands; the success of the Company's marketing focus to retail buyers; the Company's exposure to product liability claims and intellectual property claims from third parties; and the Company's reliance on the expected growth in demand for its products. For a discussion of these and other risks and uncertainties see "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's public filings with the SEC. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.

Contact Information